Published recall report · Quality failureUpdated · 1 yr 5 mo ago
Glenmark Pharmaceuticals Inc., USA recall: Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.
Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.
Current recall status is unverified. FDA does not update drug-enforcement status after publication. Check the latest official information or ask a pharmacist.
What to do
Check the lot number on your pack against this recall and follow the firm's instructions. Do not stop taking a prescribed medicine without talking to a pharmacist or doctor first.
FDA public enforcement report, opens in a new tabWhich products
Propafenone Hydrochloride Extended-Release Capsules USP, 225mg 60-count bottles, Rx Only, Mfd by: Glenmark Pharmaceuticals Limited, Pithampur, Madhya Pradesh 454775, India. NDC# 16714-825-01.
- Producer
- Glenmark Pharmaceuticals Inc., USA
- Brand
- PROPAFENONE HYDROCHLORIDE
17230819
- Dates on pack
- Lot # 17230819, exp. date Mar-25
0316714826011
0316714827018
More detail
CGMP Deviations
In the news
Reporting from news publishers. Follow the official notice for product advice.
No news stories about this recall yet.